Simcere Officially Listed on HKEX
Simcere and G1 Therapeutics Announce Exclusive License Agreement for Trilaciclib in Greater China
Simcere and Primary Peptides Launch Exclusive China Partnership
Clinical Data of Envafolimab to be Released at ASCO 2020
Simcere’s Donation for Battle Against Covid-19
Simcere, Alphamab Oncology and 3D Medicines Announce Partnership to Develop and Commercialize Subcutaneous Injectable anti-PD-L1 Antibody for Oncology Indications in Mainland China
Simcere appoints Dr. Kevin Oliver as Senior Vice President
Orencia® (abatacept injection), the innovative drug in the field of rheumatology immunity co-developed by BMS and Simcere, is approved
Simcere and GI Innovation Announce Collaboration and Exclusive License Agreement for Immunotherapy Drugs in China
Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China